Recombinant IL17A (Perakizumab Biosimilar) antibody
The Humanized Chimeric anti-IL17A (Perakizumab Biosimilar) antibody (ABIN7597907) specifically detects IL17A (Perakizumab Biosimilar).
The antibody is reactive with Human samples.
Catalog No. ABIN7597907
$401.14
Plus shipping costs $50.00, if applicable $20.00 dry ice
Shipping to:
United States
Delivery in 12 to 15 Business Days
Quick Overview for Recombinant IL17A (Perakizumab Biosimilar) antibody (ABIN7597907)
Target
IL17A (Perakizumab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Humanized
Clonality
Chimeric
Grade
Research Grade
-
-
Expression System
- Mammalian cells
-
Purpose
- Research Grade Perakizumab Biosimilar Antibody
-
Specificity
- CTLA-8, Cytotoxic T-lymphocyte-associated antigen 8, IL17, IL-17A, IL17A, CTLA8, IL-17, Interleukin-17A
-
Purification
- Protein A or G purified from cell culture supernatant.
-
Purity
- >95 % by SDS-PAGE.
-
Isotype
- IgG1 kappa
-
-
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- 0.01M PBS, pH 7.4.
-
Storage
- 4 °C,-20 °C,-80 °C
-
Storage Comment
- Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.
-
Expiry Date
- 12 months
-
-
- IL17A (Perakizumab Biosimilar)
-
Alternative Name
- Perakizumab Biosimilar
-
Target Type
- Biosimilar
-
Background
- CTLA-8, Cytotoxic T-lymphocyte-associated antigen 8, IL17, IL-17A, IL17A, CTLA8, IL-17, Interleukin-17A
-
UniProt
- Q16552
-
CAS-No
- 1331830-76-2
Target
-
You are here:
